| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| GBGB0326780.4AGB0326780D0 (en) | 2003-11-18 | 2003-11-18 | Biological materials and uses thereof |
| PCT/GB2004/004795WO2005050203A2 (en) | 2003-11-18 | 2004-11-15 | The methods for screening using ctgf and trka receptor for the identification of compounds for use in treatment of fibrosis |
| EP04798515AEP1718979A2 (en) | 2003-11-18 | 2004-11-15 | Methods of screening using ctgf and trka receptor for the identification of compounds for use in treatment of fibrosis |
| CA002546401ACA2546401A1 (en) | 2003-11-18 | 2004-11-15 | The methods for screening using ctgf and trka receptor for the identification of compounds for use in treatment of fibrosis |
| AU2004292013AAU2004292013A1 (en) | 2003-11-18 | 2004-11-15 | Methods for screening using CTGF and TRKA receptor for the identification of compounds for use in treatment of fibrosis |
| JP2006540577AJP2007515162A (en) | 2003-11-18 | 2004-11-15 | Screening method using CTGF and TRKA receptors for the identification of compounds used in the treatment of fibrosis |
| CNA2004800406378ACN1906491A (en) | 2003-11-18 | 2004-11-15 | Methods of screening using CTGF and TRKA receptor for the identification of compounds for use in treatment of fibrosis |
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| GBGB0326780.4AGB0326780D0 (en) | 2003-11-18 | 2003-11-18 | Biological materials and uses thereof |
| Publication Number | Publication Date |
|---|---|
| GB0326780D0true GB0326780D0 (en) | 2003-12-24 |
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| GBGB0326780.4ACeasedGB0326780D0 (en) | 2003-11-18 | 2003-11-18 | Biological materials and uses thereof |
| Country | Link |
|---|---|
| EP (1) | EP1718979A2 (en) |
| JP (1) | JP2007515162A (en) |
| CN (1) | CN1906491A (en) |
| AU (1) | AU2004292013A1 (en) |
| CA (1) | CA2546401A1 (en) |
| GB (1) | GB0326780D0 (en) |
| WO (1) | WO2005050203A2 (en) |
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| GB0326778D0 (en)* | 2003-11-18 | 2003-12-24 | Imp College Innovations Ltd | Biological materials and uses thereof |
| WO2006102333A2 (en)* | 2005-03-21 | 2006-09-28 | Alcon Manufacturing, Ltd. | Ophthalmic use of agents which inhibit connective tissue growth factor binding and signalling via the trka/p75ntr receptor complex |
| NZ591416A (en) | 2008-08-25 | 2012-11-30 | Excaliard Pharmaceuticals Inc | Antisense oligonucleotides directed against connective tissue growth factor and uses thereof |
| US8946172B2 (en) | 2008-08-25 | 2015-02-03 | Excaliard Pharmaceuticals, Inc. | Method for reducing scarring during wound healing using antisense compounds directed to CTGF |
| EP2169059A1 (en)* | 2008-09-25 | 2010-03-31 | Academisch Medisch Centrum bij de Universiteit van Amsterdam | Means and methods for counteracting, preventing and/or determining fibrosis or a risk of fibrosis |
| EP2221387A1 (en) | 2009-02-19 | 2010-08-25 | Université de la Méditerranée | Fibrosis susceptibility gene and uses thereof |
| BR112013019803A2 (en) | 2011-02-02 | 2019-06-11 | Excaliard Pharmaceuticals Inc | method of treating keloids or hypertrophic scars using antisense compounds aiming at connective tissue development factor (ctgf) |
| US10150989B2 (en) | 2011-08-05 | 2018-12-11 | Universite D'aix Marseille | Fibrosis susceptibility IL22RA2 gene and uses thereof |
| KR101467109B1 (en)* | 2013-07-10 | 2014-12-01 | 영남대학교 산학협력단 | Composition for preventing or treating pulmonary fibrosis comprising BIX02189 compound |
| HUE055357T2 (en) | 2014-02-05 | 2021-11-29 | VM Oncology LLC | Compositions of compounds and their applications |
| JP7671699B2 (en)* | 2019-05-30 | 2025-05-02 | サンシャイン・レイク・ファーマ・カンパニー・リミテッド | Anti-TrkA antibodies and uses thereof |
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| WO2001015729A1 (en)* | 1999-08-27 | 2001-03-08 | Fibrogen, Inc. | Connective tissue growth factor receptor, its agonists and antagonists, and their therapeutic and diagnostic uses |
| Publication number | Publication date |
|---|---|
| WO2005050203A2 (en) | 2005-06-02 |
| WO2005050203A3 (en) | 2005-11-17 |
| CA2546401A1 (en) | 2005-06-02 |
| AU2004292013A1 (en) | 2005-06-02 |
| JP2007515162A (en) | 2007-06-14 |
| EP1718979A2 (en) | 2006-11-08 |
| CN1906491A (en) | 2007-01-31 |
| Publication | Publication Date | Title |
|---|---|---|
| IL191868A0 (en) | Biological materials and uses thereof | |
| AU2003284875A8 (en) | Biological scaffolding material | |
| PL378135A1 (en) | 2-cyanopyrrolopyrimidines and pharmaceutical uses thereof | |
| GB0326780D0 (en) | Biological materials and uses thereof | |
| AP2127A (en) | Multi-carbide material manufacture and use | |
| IL172510A0 (en) | Antibodies and uses thereof | |
| GB0326778D0 (en) | Biological materials and uses thereof | |
| GB0519398D0 (en) | Biological materials and uses thereof | |
| GB2400659B8 (en) | Assay methods and materials | |
| GB0318546D0 (en) | Quinoxalinones and their use | |
| GB0300804D0 (en) | Compounds and their use | |
| GB0300805D0 (en) | Compounds and their use | |
| GB0301143D0 (en) | Compounds and their use | |
| GB0321746D0 (en) | Biological materials and uses thereof | |
| GB0318063D0 (en) | Biological material and uses thereof | |
| GB0309203D0 (en) | Biological material and uses thereof | |
| HK1091264A (en) | Biological materials and uses thereof | |
| EP1602666A4 (en) | Novel protein and its dna | |
| GB0519397D0 (en) | Biological materials and uses thereof | |
| EP1531179A1 (en) | New biological entities and the use thereof | |
| GB0321300D0 (en) | Protein structure and uses thereof | |
| GB0211496D0 (en) | Disposable materials and articles | |
| GB0316108D0 (en) | Compounds and their use | |
| GB0328147D0 (en) | Compounds and their use | |
| GB0324209D0 (en) | Compounds and their use |
| Date | Code | Title | Description |
|---|---|---|---|
| AT | Applications terminated before publication under section 16(1) |